The debate article highlights the importance of identifying sarcopenia, and the impact it has on reducing ‘physical performance’.1 It is also worth identifying that skeletal muscle is a ‘metabolic organ’, and that many of the associated adverse health outcomes may be potentiated by an endocrine mechanism. In order to screen for this, we propose the use of …